Stock Analysis
H&K (EPA:MLHK) Full Year 2023 Results
Key Financial Results
- Revenue: €301.4m (down 1.2% from FY 2022).
- Net income: €19.2m (down 62% from FY 2022).
- Profit margin: 6.4% (down from 17% in FY 2022). The decrease in margin was primarily driven by higher expenses.
- EPS: €0.54 (down from €1.83 in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
H&K's share price is broadly unchanged from a week ago.
Risk Analysis
You should learn about the 5 warning signs we've spotted with H&K (including 2 which are a bit unpleasant).
Valuation is complex, but we're helping make it simple.
Find out whether H&K is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About ENXTPA:MLHK
H&K
H&K AG, together with its subsidiary, develops, manufactures, markets, and distributes infantry and small arms for military and governmental authority personnel in Germany, the European Union, and NATO countries.
Adequate balance sheet with poor track record.